INSIDERFilingvia Quantisnow
Amyris Inc. logo

Amyris (AMRS) executive Melo bought 17,155 shares for $69.1K at $4.03

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

John Melo (executive at Amyris Inc., AMRS) reported that they bought 17,155 shares for $69.1K at $4.03 on Aug 15, 2022. After these transactions the filing shows 509,856 shares held directly.

Reporting person
Melo John
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Aug 15, 2022Open-market purchase (P)Common Stock+17,155$4.03$69.1K509,856 direct

Holdings before and after

  • Common Stock: 492,701 to 509,856 direct

Transaction codes in this filing

Open-market purchase:
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

FAQ

What did Melo report in this AMRS Form 4?

John Melo (executive at Amyris Inc., AMRS) reported that they bought 17,155 shares for $69.1K at $4.03 on Aug 15, 2022. After these transactions the filing shows 509,856 shares held directly.

How many AMRS shares does Melo hold after this filing?

The filing shows 509,856 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code P mean on an SEC Form 4?

Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

Historical context for AMRS

Earlier insider filings at AMRS

Keep researching AMRS

Quantisnow market dataNASDAQ
Amyris Inc. logo
AMRS
Amyris Inc.
Market cap
30-day
Sector
Industrials
Industry
Major Chemicals
Listed since
2010
Get push alerts for AMRS

Follow AMRS and get a push notification the moment its next story breaks.

Full AMRS profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AMRS (Amyris Inc.) and more on Quantisnow.